HaystackAnalytics to expand genomic infection diagnostic network to 100 centres

HaystackAnalytics plans to scale its network of Genomic Centres of Excellence (GCEs) to 100 centres across India over the next 12 months, aiming to make clinical-grade genomic diagnostics for infectious diseases more accessible near hospitals and patients. The company says its distributive genomics model embeds advanced testing capabilities closer to the point of care, addressing delays caused by centralised laboratory-based hub-and-spoke systems. Currently, poor access to near-point-of-care solutions and fragmented diagnostics hinder timely identification of infections, a challenge shared globally.

HaystackAnalytics has already demonstrated this model through its expanding GCE network, which brings sequencing-based diagnostics into hospital ecosystems. The goal is to enable clinicians to investigate complex infections without relying on distant specialised facilities or conventional methods. “Every diagnostic innovation ultimately has to answer one question: does it help a clinician make a better decision for the patient?” said Gaurav Srivastava, COO and Co-founder. The company envisions Indian genomics creating a scalable pathway for quick, advanced infection diagnostics.